| Vial description: |
Kerato-epithelin, RGD-CAP, Beta ig-h3 |
| Category: |
antigen |
| Raised in: |
laboratory |
| Clone: |
1 vial |
| Form: |
Purified |
| Reactivity: |
not determined |
| Purity: |
>, 95% |
| Molecular weight: |
14 kDa |
| Source: |
coli, E |
| Activity: |
to be determined |
| Range: |
broad |
| Protein number: |
Q15582 |
| Application: |
not determined |
| Storage: |
Avoid freeze/thaw cycles, Upon delivery aliquot and store at -20°, C, C for one year, Shipped at 4° |
| Description: |
Freeze thaw will destroy a percentage in every cycle and should be avoided, C in a fridge short term in a concentrated dilution, This antibody needs to be stored at + 4° |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by acr they should be stored frozen at - 24° |
| Gene target: |
TGFBI / BIGH3 (Fasciclin domain 4) |
| Short name: |
anti-TGFBI / BIGH3 (Fasciclin domain 4) Antibody |
| Technique: |
antibodies against human proteins, antibodies for, antibody to, Antibody |
| Alternative name: |
68kDa / BIGH3 (Fasciclin domain 4) (Antibody to), b-induced, antibody to-transforming growth factor |
| Alternative technique: |
antibodies |
| Alternative to gene target: |
68kDa, BIGH3 and CDB1 and CDG2 and CDGG1 and CSD and CSD1 and CSD2 and CSD3 and EBMD and LCD1, Extracellular, TGFBI and IDBG-45833 and ENSG00000120708 and 7045, TGFBI and IDBG-645854 and ENSBTAG00000009513 and 539596, Tgfbi and IDBG-157426 and ENSMUSG00000035493 and 21810, beta-induced, extracellular matrix binding, this GO :0001525 and angiogenesis and biological process this GO :0002062 and chondrocyte differentiation and biological process this GO :0005178 and integrin binding and molecular function this GO :0005515 and protein binding and molecular function this GO :0005518 and collagen binding and molecular function this GO :0005576 and extracellular region and cellular component this GO :0005578 and proteinaceous extracellular matrix and cellular component this GO :0005604 and basement membrane and cellular component this GO :0005615 and extracellular space and cellular component this GO :0005802 and trans- this GO lgi network and cellular component this GO :0005886 and plasma membrane and cellular component this GO :0007155 and cell adhesion and biological process this GO :0007162 and negative regulation of cell adhesion and biological process this GO :0007601 and visual perception and biological process this GO :0008283 and cell proliferation and biological process this GO :0030198 and extracellular matrix organization and biological process this GO :0031012 and extracellular matrix and cellular component this GO :0050840 and extracellular matrix binding and molecular function this GO :0050896 and response to stimulus and biological process this GO :0070062 and extracellular vesicular exosome and cellular component, this GO :0005178 : integrin binding, this GO :0005178 : integrin binding and also this GO :0005515 : protein binding and also this GO :0005518 : collagen binding and also this GO :0050840 : extracellular matrix binding, this GO :0005515 : protein binding, this GO :0005518 : collagen binding, this GO :0050840 : extracellular matrix binding, transforming growth factor |
| Identity: |
11771 |
| Gene: |
TGFBI |
More about : TGFBI |
| Long gene name: |
transforming growth factor beta induced |
| Synonyms gene: |
CSD3 LCD1 CSD1 CSD2 |
| Synonyms gene name: |
68kD transforming growth factor, 68kDa , beta-induced, beta-induced, transforming growth factor |
| Synonyms: |
BIGH3 CDB1 CDGG1 |
| Locus: |
5q31, 1 |
| Discovery year: |
1995-07-18 |
| GenBank acession: |
M77349 |
| Entrez gene record: |
7045 |
| Pubmed identfication: |
9463327 |
| Havana BLAST/BLAT: |
OTTHUMG00000163213 |